The EBMT/EHA CAR-T Cell Handbook

by Nicolaus Krïger (Editor), John Gribben (Editor), Christian Chabannon (Editor), Ibrahim Yakoub-Agha (Editor), Hermann Einsele (Editor)

Overview

This first open access European CAR-T Handbook, co-promoted by the European Society for Blood and Marrow Transplantation (EBMT) and the European Hematology Association (EHA), covers several aspects of CAR-T cell treatments, including the underlying biology, indications, management of side-effects, access and manufacturing issues. This book, written by leading experts in the field to enhance readers’ knowledge and practice skills, provides an unparalleled overview of the CAR-T cell technology and its  application in clinical care, to enhance readers’ knowledge and practice skills.

Product Details

ISBN-13:	9783030943530
Publisher:	Springer-Verlag New York, LLC
Publication date:	02/07/2022
Sold by:	Barnes & Noble
Format:	eBook
File size:	6 MB

About the Author

Nicolaus Kröger MD, is the current EBMT President, Professor of Medicine and Medical Director of the Department of Stem Cell Transplantation at the University Medical Center, Hamburg - Eppendorf, Germany 

John G. Gribben, MD DSc FRCP FRCPath, FMedSci, is the Past President of EHA, Professor of Medical Oncology and Director of Stem Cell Transplantation at Saint Bartholomew's Hospital, Queen Mary School of Medicine, University of London, UK

Christian Chabannon, MD, PhD, is the current chair of the Cellular Therapy&Immunobiology Working Party (CTIWP) of the EBMT, is the Head and Qualified Person of the Cell Collection and Cell Processing Facility at Institut Paoli-Calmettes, the Coordinator of the "Centre d’Investigations Cliniques en Biothérapies de Marseille", and a Professor of Cell Biology at Aix-Marseille University, France

Ibrahim Yakoub-Agha, MD, PhD, is the current chair of the Chronic Malignancies Working Party of the EBMT and holds the position of coordinating professor for the Department of Hematology at Lille Faculty of Medicine, France

Hermann Einsele, MD, FRCP, is Full Professor of Internal Medicine and has been Director of the Department of Internal Medicine II of the University Hospital Würzburg, Germany

Table of Contents

1. Introduction.- 2. The science behind CAR-T Cells.- 3. Manufacturing CAR-T Cells: the supply chain.- 4. Clinical indications for CAR-T Cells.- 5. Clinical management of patients treated with CAR-T Cells.-  6. Access to CAR-T cells.